Details

Autor(en) / Beteiligte

• Cirz, Ryan T
• Chin, Jodie K
• Andes, David R
• de Crécy-Lagard, Valérie
• Craig, William A
• Romesberg, Floyd E
• Waldor, Matt

Titel

Inhibition of mutation and combating the evolution of antibiotic resistance

Ist Teil von

• PLoS biology, 2005-06, Vol.3 (6), p.e176-e176

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2005

Quelle

MEDLINE

Beschreibungen/Notizen

• The emergence of drug-resistant bacteria poses a serious threat to human health. In the case of several antibiotics, including those of the quinolone and rifamycin classes, bacteria rapidly acquire resistance through mutation of chromosomal genes during therapy. In this work, we show that preventing induction of the SOS response by interfering with the activity of the protease LexA renders pathogenic Escherichia coli unable to evolve resistance in vivo to ciprofloxacin or rifampicin, important quinolone and rifamycin antibiotics. We show in vitro that LexA cleavage is induced during RecBC-mediated repair of ciprofloxacin-mediated DNA damage and that this results in the derepression of the SOS-regulated polymerases Pol II, Pol IV and Pol V, which collaborate to induce resistance-conferring mutations. Our findings indicate that the inhibition of mutation could serve as a novel therapeutic strategy to combat the evolution of antibiotic resistance.